StockData
GT Biopharma, Inc. logo

GT Biopharma, Inc. (GTBP) stock

GTBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$3.18−0.35 (-10.04%)

Close on Nov 17, 2026Market cap $143.45MP/E –Yield –

GT Biopharma EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

GT Biopharma's EV/EBITDA was 537.5× on Jan 29, 2021.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2021Jan 29, 2021537.5×+52.6
2020Dec 31, 2020484.9×–

More GT Biopharma figures

See a number that looks wrong?